Related references
Note: Only part of the references are listed.Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
Matteo Garibaldi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2022)
The hallmarks of myotonic dystrophy type 1 muscle dysfunction
Lauren L. Ozimski et al.
BIOLOGICAL REVIEWS (2021)
Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1
Ellen van der Plas et al.
MUSCLE & NERVE (2021)
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program
Nicholas E. Johnson et al.
NEUROLOGY (2021)
Isokinetic strength and degeneration of lower extremity muscles in patients with myotonic dystrophy; an MRI study
C. H. Steenkjaer et al.
NEUROMUSCULAR DISORDERS (2021)
Myotonic dystrophy type 1 drug development: A pipeline toward the market
Marta Pascual-Gilabert et al.
DRUG DISCOVERY TODAY (2021)
Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression
Maria Sabater-Arcis et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Regional variation of thigh muscle fat infiltration in patients with neuromuscular diseases compared to healthy controls
Tobias Greve et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2021)
HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy
Moyi Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
Maria Sabater-Arcis et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
The expanding role of MRI in neuromuscular disorders
Pierre G. Carlier et al.
NATURE REVIEWS NEUROLOGY (2020)
Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features
Tara E. Crawford Parks et al.
HUMAN MOLECULAR GENETICS (2020)
The Role of Imaging Biomarkers in the Assessment of Sarcopenia
Roberto Sanz-Requena et al.
DIAGNOSTICS (2020)
Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study
Salvatore Rossi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI
Linda Heskamp et al.
NEUROLOGY (2019)
Respiratory dysfunction in myotonic dystrophy type 1: A systematic review
A. M. Hawkins et al.
NEUROMUSCULAR DISORDERS (2019)
Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1
Christina Wei et al.
FASEB JOURNAL (2018)
Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1
Ginny R. Morriss et al.
HUMAN MOLECULAR GENETICS (2018)
Lower limb muscle magnetic resonance imaging in myotonic dystrophy type 1 correlates with the six-minute walk test and CTG repeats
Donghwi Park et al.
NEUROMUSCULAR DISORDERS (2018)
Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms
Jana R. Jenquin et al.
ACS CHEMICAL BIOLOGY (2018)
Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I
Marielle Brockhoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies
Stojan Peric et al.
JOURNAL OF NEUROLOGY (2017)
Myotonic Dystrophy Type 1 Management and Therapeutics
Cheryl A. Smith et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
Imaging of sarcopenia
Giuseppe Sergi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy
Darren R. Bisset et al.
HUMAN MOLECULAR GENETICS (2015)
Molecular mechanisms in DM1-a focus on foci
Olof Joakim Pettersson et al.
NUCLEIC ACIDS RESEARCH (2015)
GSK3β mediates muscle pathology in myotonic dystrophy
Karlie Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 Locus
Aline Huguet et al.
PLOS GENETICS (2012)
Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review
W. Kyle Mitchell et al.
FRONTIERS IN PHYSIOLOGY (2012)
Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells
E. Loro et al.
CELL DEATH AND DIFFERENTIATION (2010)
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
Paul A. Yushkevich et al.
NEUROIMAGE (2006)
Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1
G Perseghin et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2004)
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2
A Vihola et al.
NEUROLOGY (2003)
Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy
A Mankodi et al.
MOLECULAR CELL (2002)
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat
A Mankodi et al.
SCIENCE (2000)
Share Paper
